LabGenius

LabGenius

Accelerating antibody discovery with AI.

LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the discovery of next-generation therapeutic antibodies for solid tumours.

Life scienceBiotechnology & Synthetic Biologyai-drivenantibody-discoverytherapeutics

Overview

Revolutionizing Antibody Discovery

Complex antibodies, like multispecifics, are hard to engineer because the relationship between design and function is often non-intuitive. As a consequence, conventional methods are liable to deliver sub-optimal molecules which either fail in the clinic or result in poor patient outcomes.

Introducing EVA™

We’ve developed EVA™ — a highly automated discovery engine that enables the rapid identification and co-optimisation of complex therapeutic antibodies across multiple key properties.

Our platform is both modular and scalable, allowing for the efficient exploration of diverse antibody designs, ensuring that we can meet the specific needs of various therapeutic applications.

Pros (5)

  • AI-driven technology
  • Highly automated process
  • Modular and scalable platform
  • Rapid discovery capabilities
  • Focus on solid tumours

Cons (5)

  • Complex engineering challenges
  • Requires advanced technology
  • Potential high development costs
  • Limited to specific applications
  • Still in development phase

Alternatives of LabGenius

No alternatives listed. Explore all alternatives

Reviews & Ratings

No reviews yet — be the first to review.

Visit LabGenius to leave a review

Top AI tools for LabGenius

Loading...

FAQs